Literature DB >> 28671487

Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop.

Maria Pia Amato1, Tobias Derfuss2, Bernard Hemmer3, Roland Liblau4, Xavier Montalban5, Per Soelberg Sørensen6, David H Miller7.   

Abstract

Multiple sclerosis (MS) is an inflammatory and neurodegenerative demyelinating disease of the central nervous system (CNS), most likely autoimmune in origin, usually beginning in early adulthood. The aetiology of the disease is not well understood; it is viewed currently as a multifactorial disease which results from complex interactions between genetic predisposition and environmental factors, of which a few are potentially modifiable. Improving our understanding of these factors can lead to new and more effective approaches to patient counselling and, possibly, prevention and management of the disease. The 2016 focused workshop of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) addressed the topic of environmental, modifiable risk factors for MS, gathering experts from around the world, to collate experimental and clinical research into environmental factors that have been associated with the disease onset and, in a few cases, disease activity and progression. A number of factors, including infections, vitamin D deficiency, diet and lifestyle factors, stress and comorbidities, were discussed. The meeting provided a forum to analyse available evidence, to identify inconsistencies and gaps in current knowledge and to suggest avenues for future research.

Entities:  

Keywords:  Multiple sclerosis; comorbidities; environmental risk factors; infections; lifestyle; vitamin D

Year:  2018        PMID: 28671487     DOI: 10.1177/1352458516686847

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  36 in total

1.  Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach.

Authors:  Maria Pia Amato; Antonio Bertolotto; Roberto Brunelli; Paola Cavalla; Benedetta Goretti; Maria Giovanna Marrosu; Francesco Patti; Carlo Pozzilli; Leandro Provinciali; Nicola Rizzo; Nicola Strobelt; Gioacchino Tedeschi; Maria Trojano; Giancarlo Comi
Journal:  Neurol Sci       Date:  2017-08-02       Impact factor: 3.307

2.  Role of positive lifestyle activities on mood, cognition, well-being, and disease characteristics in multiple sclerosis.

Authors:  Lauren B Strober; Alexandra Becker; John J Randolph
Journal:  Appl Neuropsychol Adult       Date:  2018 Jul-Aug       Impact factor: 2.248

Review 3.  Autoimmune diseases of the brain, imaging and clinical review.

Authors:  Ghazal Shadmani; Tyrell J Simkins; Reza Assadsangabi; Michelle Apperson; Lotfi Hacein-Bey; Osama Raslan; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2021-09-07

Review 4.  Autoimmune disease of head and neck, imaging, and clinical review.

Authors:  Alireza Paydar; Zachary B Jenner; Tyrell J Simkins; Yu-Ming Chang; Lotfi Hacein-Bey; Arzu Ozturk; Andrew Birkeland; Reza Assadsangabi; Osama Raslan; Ghazal Shadmani; Michelle Apperson; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2022-05-22

5.  Oral Colonization by Candida Species in Patients with Multiple Sclerosis.

Authors:  Eliana Tomomi Shimabukuro da Cunha; Lívia Mara Alves Figueiredo-Godoi; Diogo Haddad Santos; Rafael Paterno Castello Dias Carneiro; Guilherme Sciascia do Olival; Patrícia Pimentel de Barros; Keila Narimatsu; Charles Peter Tilbery; Juliana Campos Junqueira
Journal:  Mycopathologia       Date:  2020-08-27       Impact factor: 2.574

Review 6.  Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.

Authors:  Paolo Riccio; Rocco Rossano
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 7.  The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years.

Authors:  Sergio E Baranzini; Jorge R Oksenberg
Journal:  Trends Genet       Date:  2017-10-05       Impact factor: 11.639

8.  Integrated analysis of differentially expressed genes and a ceRNA network to identify hub lncRNAs and potential drugs for multiple sclerosis.

Authors:  Tianfeng Wang; Si Xu; Li Liu; Shuang Li; Huixue Zhang; Xiaoyu Lu; Xiaotong Kong; Danyang Li; Jianjian Wang; Lihua Wang
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

9.  Pain in People with Multiple Sclerosis: Associations with Modifiable Lifestyle Factors, Fatigue, Depression, Anxiety, and Mental Health Quality of Life.

Authors:  Claudia H Marck; Alysha M De Livera; Tracey J Weiland; Pia L Jelinek; Sandra L Neate; Chelsea R Brown; Keryn L Taylor; Fary Khan; George A Jelinek
Journal:  Front Neurol       Date:  2017-09-05       Impact factor: 4.003

10.  Psychiatric and physical comorbidities and pain in patients with multiple sclerosis.

Authors:  Rogier Scherder; Neeltje Kant; Evelien T Wolf; Bas Pijnenburg; Erik Ja Scherder
Journal:  J Pain Res       Date:  2018-02-13       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.